0 followers
EpiVax Therapeutics ("EVT"), founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or prevent disease in the host.
Industries
Headquarters
Stage
Employees
Links
View full screen
Annie De Groot
View all
6 members
3 members
1 members
Coherus BioSciences
5 followers
BioMarin Pharmaceutical
20 followers
Adaptive Biotechnologies
11 followers
Eikon Therapeutics
1 follower
Dragonfly Therapeutics
Explore more companies